Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2007

01-08-2007 | Clinical Investigation

Optic disc edema in non-arteritic anterior ischemic optic neuropathy

Authors: Sohan Singh Hayreh, M. Bridget Zimmerman

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2007

Login to get access

Abstract

We investigated the clinical characteristics, time to resolution and the factors that influence it, and evolutionary pattern of optic disc edema (ODE) in non-arteritic anterior ischemic optic neuropathy (NA-AION). Our study was conducted in 591 consecutive patients (749 eyes) with NA-AION who fulfilled our inclusion criteria. On their first visit to our clinic, all patients had a detailed ophthalmic and medical history, a comprehensive ophthalmic evaluation, and stereoscopic color fundus photography and fluorescein fundus angiography. On each follow-up visit, the same ophthalmic evaluation was performed, except for fluorescein fundus angiography. The effect of steroid therapy on ODE was evaluated in a “patient choice study” in 723 eyes, i.e., patients who voluntarily opted to have (343 eyes) or not have (380 eyes) this therapy. To identify the factors that influence time to ODE resolution, parametric regression models for interval-censored data were fitted by maximum likelihood estimation using an SAS procedure. Our results indicate that the overall median time (25–75th percentile) to spontaneous resolution of ODE from the onset of visual loss was 7.9 (5.8–11.4) weeks. The ODE resolution time was longer in diabetics than in non-diabetics (p = 0.003) in the single factor model. Multi-factor analysis showed that worse initial visual field defects (p < 0.0001) and worse visual acuity (p = 0.04) were associated with a faster resolution of ODE. Those treated with steroid therapy within 2 weeks after onset of NA-AION had significantly (p = 0.0006) faster ODE resolution than untreated cases. Severity of initial visual loss and systemic diseases were identical in steroid treated and untreated patients. A characteristic evolutionary pattern of ODE in NA-AION was observed. In conclusion, our study showed that in NA-AION the time course for resolution of ODE is shorter with greater severity of initial visual field and visual acuity loss, which may relate to the number of axons permanently damaged during the acute stage. Steroid therapy was associated with shorter time to resolution of ODE. Resolution of ODE goes through a characteristic evolutionary process.
Literature
1.
go back to reference Allison PD (1995) Survival analysis using the SAS System: a practical guide. SAS Institute Inc, Cary NC, pp 61–109 Allison PD (1995) Survival analysis using the SAS System: a practical guide. SAS Institute Inc, Cary NC, pp 61–109
2.
go back to reference Arnold AC, Hepler RS (1994) Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 117:222–230PubMed Arnold AC, Hepler RS (1994) Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 117:222–230PubMed
3.
go back to reference Beck RW, Servais GE, Hayreh SS (1987) Anterior ischemic optic neuropathy IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 94:1503–1508PubMed Beck RW, Servais GE, Hayreh SS (1987) Anterior ischemic optic neuropathy IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 94:1503–1508PubMed
4.
go back to reference Dai J, Buijs R, Swaab D (2004) Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer’s disease. Br J Pharmacol 143:606–610PubMedCrossRef Dai J, Buijs R, Swaab D (2004) Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer’s disease. Br J Pharmacol 143:606–610PubMedCrossRef
5.
go back to reference Danesh-Meyer H, Savino PJ, Spaeth GL, Gamble GD (2005) Comparison of arteritic and nonarteritic anterior ischemic optic neuropathies with the Heidelberg Retina Tomograph. Ophthalmology 112:1104–1112PubMedCrossRef Danesh-Meyer H, Savino PJ, Spaeth GL, Gamble GD (2005) Comparison of arteritic and nonarteritic anterior ischemic optic neuropathies with the Heidelberg Retina Tomograph. Ophthalmology 112:1104–1112PubMedCrossRef
6.
go back to reference Foulds WS (1968) Ischaemic optic neuropathy. In: Cant JS (ed) Proceedings of the Wm MacKenzie centenary symposium on the ocular circulation in health and disease. Glasgow, Kimpton, London, pp 136–141 Foulds WS (1968) Ischaemic optic neuropathy. In: Cant JS (ed) Proceedings of the Wm MacKenzie centenary symposium on the ocular circulation in health and disease. Glasgow, Kimpton, London, pp 136–141
7.
go back to reference Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86:247–248PubMedCrossRef Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86:247–248PubMedCrossRef
8.
go back to reference Hayreh SS (1965) Pathogenesis of oedema of the optic disc (papilloedema), PhD Thesis. London University, London Hayreh SS (1965) Pathogenesis of oedema of the optic disc (papilloedema), PhD Thesis. London University, London
10.
go back to reference Hayreh SS (1969) Blood supply of the optic nerve head and its role in optic atrophy, glaucoma and oedema of the optic disc. Br J Ophthalmol 53:721–748PubMed Hayreh SS (1969) Blood supply of the optic nerve head and its role in optic atrophy, glaucoma and oedema of the optic disc. Br J Ophthalmol 53:721–748PubMed
11.
go back to reference Hayreh SS (1972) Optic disc vasculitis. Br J Ophthalmol 56:652–670PubMed Hayreh SS (1972) Optic disc vasculitis. Br J Ophthalmol 56:652–670PubMed
12.
go back to reference Hayreh SS (1974) Anterior ischaemic optic neuropathy I. Terminology and pathogenesis. Br J Ophthalmol 58:955–963PubMed Hayreh SS (1974) Anterior ischaemic optic neuropathy I. Terminology and pathogenesis. Br J Ophthalmol 58:955–963PubMed
13.
go back to reference Hayreh SS (1974) Anterior ischaemic optic neuropathy II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthalmol 58:964–980PubMed Hayreh SS (1974) Anterior ischaemic optic neuropathy II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthalmol 58:964–980PubMed
14.
go back to reference Hayreh SS (1974) Anterior ischaemic optic neuropathy III. Treatment, prophylaxis, and differential diagnosis. Br J Ophthalmol 58:98l–989 Hayreh SS (1974) Anterior ischaemic optic neuropathy III. Treatment, prophylaxis, and differential diagnosis. Br J Ophthalmol 58:98l–989
15.
go back to reference Hayreh SS (1974) Pathogenesis of cupping of the optic disc. Br J Ophthalmol 58:863–876PubMed Hayreh SS (1974) Pathogenesis of cupping of the optic disc. Br J Ophthalmol 58:863–876PubMed
16.
go back to reference Hayreh SS (1975) Anterior ischemic optic neuropathy. Springer, Berlin Heidelberg New York Hayreh SS (1975) Anterior ischemic optic neuropathy. Springer, Berlin Heidelberg New York
17.
go back to reference Hayreh SS (1977) Optic disc edema in raised intracranial pressure V. Pathogenesis. Arch Ophthalmol 95:1553–1565PubMed Hayreh SS (1977) Optic disc edema in raised intracranial pressure V. Pathogenesis. Arch Ophthalmol 95:1553–1565PubMed
18.
go back to reference Hayreh SS (1978) Fluids in the anterior part of the optic nerve in health and disease. Surv Ophthalmol 23:1–25PubMedCrossRef Hayreh SS (1978) Fluids in the anterior part of the optic nerve in health and disease. Surv Ophthalmol 23:1–25PubMedCrossRef
19.
go back to reference Hayreh SS (1981) Anterior ischemic optic neuropathy V. Optic disc edema an early sign. Arch Ophthalmol 99:1030–1040PubMed Hayreh SS (1981) Anterior ischemic optic neuropathy V. Optic disc edema an early sign. Arch Ophthalmol 99:1030–1040PubMed
20.
go back to reference Hayreh SS (1981) Anterior ischemic optic neuropathy. Arch Neurol 38:675–678PubMed Hayreh SS (1981) Anterior ischemic optic neuropathy. Arch Neurol 38:675–678PubMed
21.
go back to reference Hayreh SS (1985) Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol 59:217–246PubMedCrossRef Hayreh SS (1985) Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol 59:217–246PubMedCrossRef
22.
go back to reference Hayreh SS (1990) Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 4:25–41PubMed Hayreh SS (1990) Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 4:25–41PubMed
23.
go back to reference Hayreh SS (1996) Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am 9:407–442 Hayreh SS (1996) Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am 9:407–442
24.
go back to reference Hayreh SS (2001) The blood supply of the optic nerve head and the evaluation of it: myth and reality. Prog Retin Eye Res 20:563–593PubMedCrossRef Hayreh SS (2001) The blood supply of the optic nerve head and the evaluation of it: myth and reality. Prog Retin Eye Res 20:563–593PubMedCrossRef
25.
go back to reference Hayreh SS (2002) Diabetic papillopathy and nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 47:600–602PubMedCrossRef Hayreh SS (2002) Diabetic papillopathy and nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 47:600–602PubMedCrossRef
26.
27.
go back to reference Hayreh SS (2004) Posterior ischaemic optic neuropathy: clinical features, pathogenesis and management. Eye 18:1188–1206PubMedCrossRef Hayreh SS (2004) Posterior ischaemic optic neuropathy: clinical features, pathogenesis and management. Eye 18:1188–1206PubMedCrossRef
28.
go back to reference Hayreh SS, Jonas JB (2001) Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology 108:1586–1594PubMedCrossRef Hayreh SS, Jonas JB (2001) Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology 108:1586–1594PubMedCrossRef
29.
go back to reference Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766–780PubMed Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766–780PubMed
30.
go back to reference Hayreh SS, Massanari RM, Yamada T, Hayreh SMS (1981) Experimental allergic encephalomyelitis I. Optic nerve and central nervous system manifestations. Invest Ophthalmol Vis Sci 21:256–269PubMed Hayreh SS, Massanari RM, Yamada T, Hayreh SMS (1981) Experimental allergic encephalomyelitis I. Optic nerve and central nervous system manifestations. Invest Ophthalmol Vis Sci 21:256–269PubMed
31.
go back to reference Hayreh SS, Podhajsky P (1979) Visual field defects in anterior ischemic optic neuropathy. Doc Ophthalmol Proc Ser 19:53–71 Hayreh SS, Podhajsky P (1979) Visual field defects in anterior ischemic optic neuropathy. Doc Ophthalmol Proc Ser 19:53–71
32.
go back to reference Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123:285–296PubMed Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123:285–296PubMed
33.
go back to reference Hayreh SS, Podhajsky PA, Zimmerman B (1997) Non-arteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 124:641–647PubMed Hayreh SS, Podhajsky PA, Zimmerman B (1997) Non-arteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 124:641–647PubMed
34.
go back to reference Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509–520PubMedCrossRef Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509–520PubMedCrossRef
35.
go back to reference Hayreh SS, Weingeist TA (1980) Experimental occlusion of the central artery of the retina l. Ophthalmoscopic and fluorescein fundus angiographic studies. Br J Ophthalmol 64:896–912PubMed Hayreh SS, Weingeist TA (1980) Experimental occlusion of the central artery of the retina l. Ophthalmoscopic and fluorescein fundus angiographic studies. Br J Ophthalmol 64:896–912PubMed
36.
go back to reference Hayreh SS, Zahoruk RM (1981) Anterior ischemic optic neuropathy VI. In juvenile diabetics. Ophthalmologica 182:13–28PubMedCrossRef Hayreh SS, Zahoruk RM (1981) Anterior ischemic optic neuropathy VI. In juvenile diabetics. Ophthalmologica 182:13–28PubMedCrossRef
37.
38.
go back to reference Hayreh SS, Zimmerman B (2005) Visual field abnormalities in non-arteritic anterior ischemic optic neuropathy: their pattern and prevalence at the initial presentation. Arch Ophthalmol 123:1554–1562PubMedCrossRef Hayreh SS, Zimmerman B (2005) Visual field abnormalities in non-arteritic anterior ischemic optic neuropathy: their pattern and prevalence at the initial presentation. Arch Ophthalmol 123:1554–1562PubMedCrossRef
39.
go back to reference Jonas JB, Kreissig I, Degenring RF (2002) Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:782–783PubMedCrossRef Jonas JB, Kreissig I, Degenring RF (2002) Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:782–783PubMedCrossRef
40.
go back to reference Jonas JB, Söfker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425–427PubMedCrossRef Jonas JB, Söfker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425–427PubMedCrossRef
41.
go back to reference Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927PubMedCrossRef Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927PubMedCrossRef
42.
go back to reference McLeod D, Marshall J, Kohner EM (1980) Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol 64:247–261PubMed McLeod D, Marshall J, Kohner EM (1980) Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol 64:247–261PubMed
Metadata
Title
Optic disc edema in non-arteritic anterior ischemic optic neuropathy
Authors
Sohan Singh Hayreh
M. Bridget Zimmerman
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2007
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-006-0494-0

Other articles of this Issue 8/2007

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2007 Go to the issue

Announcements

Announcements